194 related articles for article (PubMed ID: 15093892)
1. FDG-PET in radiotherapy treatment planning: Pandora's box?
Paulino AC; Johnstone PA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):4-5. PubMed ID: 15093892
[No Abstract] [Full Text] [Related]
2. In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4-5.
MacManus M; Hicks R; Bayne M; Leong T; Peters L; Ball D
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):1005-6; author reply 1006. PubMed ID: 15465222
[No Abstract] [Full Text] [Related]
3. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
4. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?: in regard to Devic et al. (Int J Radiat Oncol Biol Phys 2010).
Hatt M; Visvikis D
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1605. PubMed ID: 21092836
[No Abstract] [Full Text] [Related]
5. Response to radiation.
Rosenzweig KE; Fox JL; Giraud P
Semin Radiat Oncol; 2004 Oct; 14(4):322-5. PubMed ID: 15558507
[TBL] [Abstract][Full Text] [Related]
6. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
Laking G; Price P
Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
[No Abstract] [Full Text] [Related]
7. Radiation-induced esophagitis on FDG PET imaging.
Bhargava P; Reich P; Alavi A; Zhuang H
Clin Nucl Med; 2003 Oct; 28(10):849-50. PubMed ID: 14508282
[No Abstract] [Full Text] [Related]
8. Role of FDG-PET in the diagnosis and management of lung cancer.
Oyen WJ; Bussink J; Verhagen AF; Corstens FH; Bootsma GP
Expert Rev Anticancer Ther; 2004 Aug; 4(4):561-7. PubMed ID: 15270660
[TBL] [Abstract][Full Text] [Related]
9. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
10. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of PET using FDG in the diagnosis of lung cancer--first results].
Rubinstein R; Breuer R; Chisin R
Harefuah; 2001 Feb; 140(2):100-3, 191. PubMed ID: 11242909
[TBL] [Abstract][Full Text] [Related]
12. Critical review of PET-CT for radiotherapy planning in lung cancer.
Senan S; De Ruysscher D
Crit Rev Oncol Hematol; 2005 Dec; 56(3):345-51. PubMed ID: 15990331
[TBL] [Abstract][Full Text] [Related]
13. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
[TBL] [Abstract][Full Text] [Related]
14. PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Freudenberg LS; Rosenbaum SJ; Beyer T; Bockisch A; Antoch G
Radiol Clin North Am; 2007 Jul; 45(4):639-44, v. PubMed ID: 17706528
[TBL] [Abstract][Full Text] [Related]
15. Small bowel metastasis from lung cancer detected on FDG PET/CT.
Tulchinsky M; Coquia S; Wagner H
Clin Nucl Med; 2009 Jul; 34(7):446-8. PubMed ID: 19542953
[No Abstract] [Full Text] [Related]
16. Choroidal and extraocular muscle metastases from non-small-cell lung carcinoma: F-18 FDG PET/CT imaging.
Nguyen BD; Roarke MC
Clin Nucl Med; 2008 Feb; 33(2):118-21. PubMed ID: 18209534
[No Abstract] [Full Text] [Related]
17. Value of FDG PET in the management of NSCLC.
Ukena D; Hellwig D
Lung Cancer; 2004 Aug; 45 Suppl 2():S75-8. PubMed ID: 15552785
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
Strobel K; Schaefer NG; Husarik DB; Hany TF; Steinert H
Clin Nucl Med; 2006 Oct; 31(10):624-6. PubMed ID: 16985370
[No Abstract] [Full Text] [Related]
19. FDG PET: advantages for staging the mediastinum?
Franzius C
Lung Cancer; 2004 Aug; 45 Suppl 2():S69-74. PubMed ID: 15552784
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET imaging in small cell lung cancer: any value?
Lassen U
Lung Cancer; 2002 Jul; 37(1):7. PubMed ID: 12057860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
